Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMycelx Di Regulatory News (MYX)

Share Price Information for Mycelx Di (MYX)

Share Price is delayed by 15 minutes
Get Live Data
64.00    2.00 (3.23%)
Bid:
63.00
Ask:
65.00
Spread: 2.00 (3.175%)
Market Cap: £15.59m
MYX Live PriceLast checked at - London Stock Exchange

Intraday Mycelx Di Share Chart

Board Changes

23 Mar 2021 07:00

RNS Number : 1045T
MyCelx Technologies Corporation
23 March 2021
 

23 March 2021

 

MYCELX TECHNOLOGIES CORPORATION (AIM: MYX)

 

Board Changes

 

MYCELX Technologies Corporation ("MYCELX" or the "Company"), the clean water and clean air technology experts, announces that Tim Eggar intends to step down from his role as Non-Executive Chairman at the Annual General Meeting to be held in July 2021.

 

Mr. Eggar joined MYCELX in 2011, steering the Company through its IPO, growth, and the recent challenging period. His considerable experience in the Energy sector and international business expertise has been invaluable in establishing the Company as a leading provider of sustainable water treatment solutions to the global market.

 

Mr. Tom Lamb, Non-Executive Director, Chairman of the Compensation Committee, and a member of the Audit and Nomination Committees, will assume the role of Chairman following Mr. Eggar's departure.

 

Mr. Lamb joined the Board in July 2019, bringing a wealth of strategic and operating expertise in a broad range of roles across the industrial and technology sectors. He has spent over 30 years driving organic growth and leading businesses in multiple international settings, including serving in a number of executive leadership roles in both public and private companies.

 

The Company will continue to review the balance of the board and would consider making a further Independent Non-Executive Director appointment in due course such that the Board has three Independent Directors including the Chairman.

 

Mr. Eggar, out-going Non-Executive Chairman, said:

 

"Following the Company's successful navigation of the COVID-19 pandemic, the time is right for me to step down from the Board of MYCELX. I have greatly enjoyed my time at the Company, and the opportunities it has given me to support its development. I leave knowing that the business is well placed to capture the very significant opportunity that exists in delivering clean water and air solutions, and helping our customers to achieve their sustainability goals. The next chapter of the MYCELX story is set to be a very exciting one, and I leave the Company in the safest of hands at both Board and senior management levels. I am grateful for the support I have received during my tenure, and look forward to watching MYCELX's continued success."

 

Connie Mixon, CEO, said:

 

"On behalf of us all at MYCELX, I would like to thank Tim for his many years of insightful support of the Company. Under his guidance, MYCELX has expanded into new territories and diversified its patented product offering. As the global economic recovery takes shape, MYCELX is well placed to benefit from a resurgence in bidding activity in the oil and gas sector, in addition to the other markets where we operate. Tim has been instrumental in helping us get to where we are today, empowering leadership to take the company in new directions, and we owe him a considerable debt of gratitude.

 

We are pleased to have a successor of Tom's calibre, and look forward to his continuing strong support as he assumes the role of Chairman."

 

 

 

For further information please contact: 

 

MYCELX Technologies Corporation

Connie Mixon, CEO

Kim Slayton, CFO

 

 

 

Tel: +1 888 306 6843

Canaccord Genuity, Nominated Adviser

Henry Fitzgerald-O'Connor

Georgina McCooke

 

 

Tel: + 44 20 7523 8000

Celicourt

Mark Antelme

Jimmy Lea

 

Tel: +44 20 8434 2754

 

Notes to Editors

Through its revolutionary oil-free water technology, MYCELX brings its customers material benefits in terms of performance enhancement, cost savings and significantly improved environmental footprints. Working beyond any ordinary filtration methods, MYCELX's proprietary technology achieves oil removal to less than one part per million. MYCELX supports leading international customers across the oil & gas value chain, as well as other industrial users. MYCELX also provides advanced air filtration technology for manufacturing and industrial facilities, effectively removing oil particles and biologicals to maintain continuous and safe air quality levels.

For more information, visit www.MYCELX.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOADKBBQCBKDNNB
Date   Source Headline
14th May 20217:00 amRNSPFAS System Validation
13th Apr 20211:49 pmRNSGrant of Options
23rd Mar 20217:00 amRNSBoard Changes
17th Mar 20213:37 pmRNSHolding(s) in Company
17th Mar 20212:35 pmRNSHolding(s) in Company
15th Mar 20217:00 amRNSHolding(s) in Company
2nd Mar 20217:00 amRNSTrading Update
18th Feb 20217:00 amRNSSale of MYCELX property in Duluth, USA
17th Feb 20214:32 pmRNSHolding(s) in Company
5th Jan 20212:32 pmRNSHolding(s) in Company
4th Jan 20217:00 amRNSHolding(s) in Company
27th Oct 20202:55 pmRNSResult of Annual Meeting
2nd Oct 20202:56 pmRNSNotice of Annual Meeting
22nd Sep 20207:00 amRNSHalf Year Results Statement
4th Sep 20207:00 amRNSAppointment of Nominated Adviser and Sole Broker
7th Aug 202011:50 amRNSDirector/PDMR Shareholding
22nd Jun 20207:00 amRNSContract extension with SABIC
19th Jun 20207:00 amRNSAnnual Financial Report
27th May 20207:00 amRNSFinal Results for the year ending 31 December 2019
11th May 20207:00 amRNSNew Project Award
14th Apr 20207:00 amRNSTrading Update
9th Mar 20207:00 amRNSClosure of Restricted Stock Line
5th Mar 20207:00 amRNSTrading Update
13th Dec 201910:25 amRNSBlock listing Interim Review
4th Nov 20197:00 amRNSTrading Update
16th Sep 20197:00 amRNSHalf Year Results Statement
20th Aug 201912:42 pmRNSHolding(s) in Company
16th Aug 20193:02 pmRNSDirector Shareholding
29th Jul 20197:00 amRNSDirectorate Changes
26th Jul 20197:00 amRNSAppointment of Nominated Adviser & Broker
22nd Jul 20191:34 pmRNSHolding(s) in Company
10th Jul 201912:57 pmRNSResult of Annual Meeting
14th Jun 20197:00 amRNSTrading Update
11th Jun 20197:00 amRNSBlock listing Interim Review
6th Jun 20197:00 amRNSIssue of Equity
31st May 20191:57 pmRNSAnnual Financial Report
13th May 20197:00 amRNSFinal Results for the year ending 31 December 2018
28th Mar 20197:00 amRNSHolding(s) in Company
15th Mar 20197:00 amRNSHolding(s) in Company
15th Mar 20197:00 amRNSHolding(s) in Company
13th Mar 20197:00 amRNSIssue of Equity
28th Feb 20194:54 pmRNSResults of Fundraising
28th Feb 20197:00 amRNSProposed $1.8 million Placing
13th Feb 201910:22 amRNSTrading Update
21st Dec 20187:00 amRNSHolding(s) in Company
11th Dec 20187:15 amRNSDirectorate Changes
7th Dec 20187:00 amRNSBlock Admission Interim Update
29th Nov 20187:00 amRNSNew Project Award and Trading Update
8th Oct 20187:00 amRNSNew Project Award and Trading Update
12th Sep 20187:00 amRNSHalf Year Results Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.